3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lung Neoplasms
3
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
6
Gemcitabine
6
Psychiatric Rehabilitation
5
Early Intervention, Educational
5
Cisplatin
5
Cetuximab
5
cediranib
4
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Fluorouracil
4
Carboplatin
4
Bevacizumab
4
Trastuzumab
3
Standard of Care
3
Radiotherapy
3
Pemetrexed
3
Paclitaxel
3
Methods
3
Irinotecan
3
Erlotinib Hydrochloride
3
Docetaxel
3
trametinib
2
X-Rays
2
Specimen Handling
2
Mental Status and Dementia Tests
2
Interleukin-12 Subunit p35
2
Fluorodeoxyglucose F18
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Radionuclide Imaging
×
Thoracic
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled